Header Logo

Connection

NAVEEN PEMMARAJU to CTLA-4 Antigen

Back to Details
This is a "connection" page, showing publications NAVEEN PEMMARAJU has written about CTLA-4 Antigen.
NAVEEN PEMMARAJU
Connection Strength
0.031
CTLA-4 Antigen
  1. Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study. Cancer Discov. 2019 03; 9(3):370-383.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.